Funds and ETFs Bioventus Inc.

Equities

BVS

US09075A1088

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.07 USD -1.93% Intraday chart for Bioventus Inc. -10.55% -22.77%

ETFs positioned on Bioventus Inc.

Name Weight AuM 1st Jan change Investor Rating
0.00% 9 M€ +5.51% -
0.00% 18 M€ +3.26% -
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.15 USD
Average target price
8 USD
Spread / Average Target
+92.77%
Consensus
  1. Stock Market
  2. Equities
  3. BVS Stock
  4. Funds and ETFs Bioventus Inc.